GSK PLC SP. ADR/2 NEW (GS70) — Defensive Interval Ratio
GSK PLC SP. ADR/2 NEW (GS70) has a Defensive Interval Ratio of 131 days as of June 2026. Defensive assets of €7.71 Billion (cash €-, short-term investments €1.00 Million, receivables €7.71 Billion) cover 131 days of daily cash needs of €59.00 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
GSK PLC SP. ADR/2 NEW Defensive Interval Ratio (2021–2025)
This chart shows how GSK PLC SP. ADR/2 NEW's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 131 days, meaning defensive assets of €7.71 Billion can fund 131 days of operations without new revenue. For the complete balance sheet picture, see GS70 current and non-current assets.
Annual Defensive Interval Ratio for GSK PLC SP. ADR/2 NEW (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See GS70 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 101 days | €5.92 Billion | €58.61 Million/day | €- | €9.00 Million | ▲ +7 days |
| 2024 | 94 days | €5.58 Billion | €59.44 Million/day | €- | €21.00 Million | ▼ -47 days |
| 2023 | 141 days | €8.15 Billion | €57.72 Million/day | €- | €2.25 Billion | ▼ -12 days |
| 2022 | 154 days | €9.61 Billion | €62.49 Million/day | €- | €4.15 Billion | ▲ +56 days |
| 2021 | 97 days | €6.31 Billion | €64.85 Million/day | €- | €61.00 Million | — |